As of November 2024 Arovella Therapeutics has 711.48M shares outstanding, a increase of 29.45% from 2023. It represents the total number of shares of a company that are owned by all its shareholders, including both public investors and company insiders.
Year | Shares outstanding | Change |
---|---|---|
2023 | 711.48M | 29.45% |
2022 | 549.62M | 66.10% |
2021 | 330.89M | 97.07% |
2020 | 167.91M | - |